Kratom Use Surge Prompts Urgent Compliance Call for Merchants

Kratom Use Surge Prompts Urgent Compliance Call for Merchants

Milwaukee, WI – A recent study published in the journal Addiction, and highlighted by SciTechDaily, reveals a dramatic surge in kratom use across the United States, accompanied by a significant increase in severe health outcomes. This news item underscores a critical juncture for the kratom industry, particularly for merchants navigating its complex regulatory landscape.

What Happened: A 6,500% Increase in Exposures

The study's findings are stark: reported kratom exposures to U.S. poison centers skyrocketed from just 19 cases in 2010 to 1,242 in 2023, representing an astounding 6,500% increase. Cases involving severe medical outcomes—defined as life-threatening conditions, lasting disability, or death—also escalated, from zero in 2010 to 158 in 2023. Dr. Ryan Feldman, a senior author from the Medical College of Wisconsin, noted that states with kratom bans consistently recorded lower exposure rates, fewer severe cases, and reduced healthcare utilization compared to states with consumer protection measures or no regulations. The research indicates that kratom, while often marketed for pain relief or mood enhancement, can act similarly to opioids at higher doses and has been linked to serious health effects like seizures, irregular heart rhythms, liver damage, and breathing problems.

Why This Matters to Kratom Merchants and Consumers

For consumers, these findings serve as a serious warning about the potential risks associated with kratom, especially when products are unregulated or used in combination with other substances. The "life-changing consequences" highlighted by the report demand heightened caution and informed decision-making regarding kratom consumption.

For kratom merchants, this surge in adverse events and the clear link between stricter regulations and better outcomes signal an inevitable increase in scrutiny from legislators and regulatory bodies. The industry's rapid growth without comprehensive federal oversight means states are left to set their own regulations, leading to a patchwork of laws. The ongoing debate among legislatures on how best to regulate kratom is set to intensify, potentially leading to more stringent consumer protection laws, or even bans, in previously unregulated areas.

Compliance Implications and Merchant Responsibilities

Given the escalating concerns, the compliance landscape for kratom merchants is becoming increasingly demanding. The lack of FDA approval and federal scheduling places the onus on states to establish safety standards, and this study provides strong evidence for states to enact or bolster protective measures.

High-risk merchants, in particular, must prioritize robust product safety and transparency to mitigate legal and reputational risks. Key areas of focus include:

• Certificates of Analysis (COAs) and Lab Testing: It is no longer sufficient to merely claim product purity. Merchants must provide comprehensive, third-party Certificates of Analysis for all products, verifying the absence of heavy metals, pesticides, microbial contaminants, and adulterants. Furthermore, accurate testing for alkaloid content, specifically mitragynine and 7-hydroxymitragynine, is crucial for informing consumers about potency and potential effects. This directly addresses concerns about "stronger, unregulated products" contributing to adverse outcomes.
• Regulatory Adherence: Merchants must strictly adhere to existing state-level Kratom Consumer Protection Act (KCPA) laws where they are enacted. For those operating in unregulated states, proactively adopting KCPA-like standards—including age restrictions, clear and accurate labeling, and avoiding unsubstantiated health claims—is a critical best practice to demonstrate responsible conduct and preempt potential bans.
• Responsible Marketing: The industry must move away from misleading claims. Accurate product descriptions and clear warnings about potential risks, especially when combined with other substances, are paramount.

The exponential rise in kratom use and associated adverse events, as detailed by SciTechDaily, serves as a stark reminder that proactive, rigorous compliance is essential for the long-term viability and public acceptance of the kratom industry. Merchants who embrace transparency and stringent quality control will be best positioned to navigate the evolving regulatory environment and safeguard both their businesses and consumers.